Statera Biopharma Competitors and Similar CompaniesClear all
Statera Biopharma's competitors and similar companies include Luna Innovations, CureVac, Biocon and Shanghai Junshi Biosciences.
 Statera Biopharma Statera Biopharma (formerly known as Cytocom) is a pre-clinical and clinical biopharmaceutical company that develops product candidates for treating diseases involving immune system dysfunction. |  Luna Innovations Luna Innovations is a company that manufactures and develops fiber optic measurement systems. |  Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | |||
Founding Date | Founding Date 2003 | Founding Date 1990 | Founding Date 2000 | Founding Date 1978 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Fort Collins, US HQ Fort Collins, US | Locations Roanoke, US HQ Cologne, DE Dubai, AE Camberley, GB Dorchester, GB Portishead, GB Ann Arbor, US see more | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Shanghai, CN HQ |
Employees | Employees 16 | Employees 337 | Employees 82517% decrease | Employees 16,5612% increase | Employees 2,578 |
Valuation ($) | Valuation ($) 21.4 k | Valuation ($) 59.2 m | Valuation ($) 648.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.5m (FY, 2021) | Revenue (est.) $109.5m (FY, 2022) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) ¥2.4b (FY, 2025) |
Cost of goods | Cost of goods $488.3k (FY, 2021) | Cost of goods $43m (FY, 2022) | Cost of goods €9.7m (FY, 2024) | Cost of goods ₹56.9b (FY, 2026) | Cost of goods ¥466.5m (FY, 2025) |
Gross profit | Gross profit $998.7k (FY, 2021) | Gross profit $66.5m (FY, 2022) | Gross profit €534.4m (FY, 2024) | Gross profit ₹115.8b (FY, 2026) | Gross profit ¥2b (FY, 2025) |
Net income | Net income ($101.9m) (FY, 2021) | Net income $9.3m (FY, 2022) | Net income €162.2m (FY, 2024) | Net income ₹3.7b (FY, 2026) | Net income (¥1b) (FY, 2025) |
Operating ⚠ | |||||
Facility Space Leased, sq. ft. | Facility Space Leased, sq. ft. 187 (FY, 2021) | Facility Space Leased, sq. ft. 186.6 k (FY, 2022) | Facility Space Leased, sq. ft. N/A | Facility Space Leased, sq. ft. N/A | Facility Space Leased, sq. ft. N/A |
Funding | |||||
Total funding raised | Total funding raised $ 12.2m | Total funding raised $ 13.1m | Total funding raised $ 1.1b | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Luna Innovations
HQ
Roanoke, US
Employees
337
Luna Innovations is a company that manufactures and develops fiber optic measurement systems.
View company
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View companyShanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,578
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company